# Regeneron Ireland Designated Activity Company, Limerick, Ireland – FDA Inspections

Source: https://www.keypedia.com/companies/regeneron-ireland-designated-activity-company/74d229ed-bddb-4f75-bb07-281189fd53d4

> Inspection records and compliance data for Regeneron Ireland Designated Activity Company in Limerick. 3 FDA inspections on record, 1 Form 483, last inspected March 14, 2023.

---

## Details

- Name: Regeneron Ireland Designated Activity Company
- FEI Number: 3011684330
- Address Line 1: Raheen Business Park
- City: Limerick
- Country Name: Ireland
- Address: Raheen Business Park, Limerick, Ireland
- Country: Ireland

## Related Documents

- [483 - Regeneron Ireland Designated Activity Company - Unknown Date](https://www.keypedia.com/records/483/regeneron-ireland-designated-activity-company/2bd5dd2c-f511-4a52-8cf4-d76d8565274d) — source: FDA, date: Invalid Date
- [483 - Regeneron Ireland Designated Activity Company - 2023-03-14](https://www.keypedia.com/records/483/regeneron-ireland-designated-activity-company/3b36a27d-e109-46fb-98aa-8764e14b2f9c) — source: FDA, date: March 14, 2023
- [FDA Inspection 1201692 - Regeneron Ireland Designated Activity Company - 2023-03-14](https://www.keypedia.com/records/fda_inspections/regeneron-ireland-designated-activity-company/1a3378cc-8677-4e2b-9649-aa283ccd308f) — source: FDA, date: March 14, 2023
- [483 - Regeneron Ireland Designated Activity Company - 2021-05-07](https://www.keypedia.com/records/483/regeneron-ireland-designated-activity-company/b54d08fc-15d6-4b33-8cb0-c7cd05c54067) — source: FDA, date: May 7, 2021
- FDA Inspection 1117521 - Regeneron Ireland Designated Activity Company - 2019-09-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 27, 2019
- FDA Inspection 1034098 - Regeneron Ireland Designated Activity Company - 2017-12-05 — source: FDA, date: December 5, 2017

## Related Companies

- [WuXi Biologics Ireland Limited](https://www.keypedia.com/companies/wuxi-biologics-ireland-limited/e760930a-5cbb-4b0f-ac1a-8eb5be3948c1)
- [ANTHEM BIOSCIENCES PRIVATE LIMITED - Phase II](https://www.keypedia.com/companies/anthem-biosciences-private-limited-phase-ii/df5d2c40-b402-492b-9369-42c7f15f0a08)
- [Daito Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/daito-pharmaceutical-co-ltd/3a27bbaf-60c1-44b3-acf3-48f8935483e8)
- [Wuxi Biologics Co Ltd](https://www.keypedia.com/companies/wuxi-biologics-co-ltd/67a28116-624d-42f6-adae-18cf80094862)
- [Hovione LLC](https://www.keypedia.com/companies/hovione-llc/06b4417a-5377-4e73-8076-71d3066fa8f0)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/b4ab6750-9275-47bd-a575-c425b82b300d)
- [Genzyme Corporation](https://www.keypedia.com/companies/genzyme-corporation/b597b205-d758-426b-bc64-09970b3a1b83)
- [KBI Biopharma, Inc.](https://www.keypedia.com/companies/kbi-biopharma-inc/c19eb9d6-d05c-437c-b018-992dba71d288)
- [Chugai Pharma Manufacturing Co. Ltd. (CPMC)](https://www.keypedia.com/companies/chugai-pharma-manufacturing-co-ltd-cpmc/946be668-0540-474b-822b-8a4a81e5284f)
- [Kyowa Kirin Co., Ltd.](https://www.keypedia.com/companies/kyowa-kirin-co-ltd/9d964de3-aa1c-4983-801e-474266e4b6d2)

## Related Officers

- [Sarah A. Johnson](https://www.keypedia.com/people/sarah-a-johnson/bb59c0e2-87ab-4958-8d33-463382ab7937)
- [Madushini N. Dharmasena](https://www.keypedia.com/people/madushini-n-dharmasena/c6dbff15-4c5f-475e-8ec1-581d8e65f76c)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)